With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

Obesity has become a growing concern worldwide, and GLP-1 drugs have brought relief to millions struggling with weight ...

Pfizer's experimental drug, berobenatide, is designed to stay attached longer to a blood protein called albumin, helping prevent it from breaking down too quickly.

By Michael Erman NEW YORK, June 6 (Reuters) - Pfizer presented data on Saturday that showed a monthly dose of an experimental ...

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...